What sounds like “just lifting weights” turned into a full lifestyle shift as 90 days of structured bodybuilding training, strict nutrition, progressive overload, and disciplined recovery began to ...

The deal values the D2C nutraceutical brand at Rs 1,583 crore as it co-develops oral GLP-1 delivery systems. The deal comes ...

Despite a significant net loss, Moderna Inc (MRNA) showcases robust cost management and strategic international growth plans.

Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11)Reports ...

Tarique Rahman, the scion of a political dynasty, is set to become the prime minister. This was the first election in Bangladesh since student-led protests toppled the last government in 2024.

Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11)Reports full-year revenue of $1.9 billion, GAAP net loss of $(2.8) billion and GAAP diluted EPS o ...

Experienced patent litigation duo expands the firm’s capabilities in sophisticated pharmaceutical and biotechnology disputes ...

After serious injuries, burns, fractures, or major surgeries, the body normally repairs damaged tissues and restores movement. However, in some patients, the healing process takes an unexpected and ...

Moderna, Inc. (NASDAQ:MRNA) reported better-than-expected fourth quarter results on Thursday, though shares fell 0.8% with the company disclosing a regulatory setback for its influenza vaccine in the ...

Scott Davis, Melius Research: Asked when the 80/20 simplification would shift from being a headwind to a tailwind. Pine indicated "2026 is kind of an inflection point," focusing on sales force ...

Moderna MRNA incurred a loss of $2.11 per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $2.60. In the year-ago period, the company had reported a loss of ...